BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

National Foundation for Cancer Research Co-Founder Honored by Google


9/19/2011 6:01:53 AM

BETHESDA, Md., Sept. 16, 2011 /PRNewswire/ -- National Foundation for Cancer Research (NFCR) co-founder Albert Szent-Gyorgyi, is being honored today, by Google on his 118th birthday, for his discovery of vitamin-C. The honor is a tribute to a life full of discoveries. Dr. Szent-Gyorgyi went on to co-found the NFCR along with entrepreneur Franklin C. Salisbury in 1973, so that scientists could find funding for high-risk, high reward research.

"Dr. Szent-Gyorgyi was committed to the notion that remarkable scientific discoveries begin when a scientist discovers an unanticipated event in a research project," said Sujuan Ba, Ph.D., Chief Operating Officer of NFCR. "Funding to further that research is very, very difficult to find."

Dr. Szent-Gyorgyi received the 1937 Nobel Prize for Physiology and Medicine for his study on vitamin-C and cell respiration and continued to be a leading advocate for developing resources that provide scientists with the financial support necessary to pursue novel cancer research ideas. In 1973, he changed the face of cancer research funding by co-founding the National Foundation for Cancer Research.

Due to that notion, the National Foundation for Cancer Research has now spent over $288 million to provide scientists with the financial support to discover cancer's molecular mysteries and translating these discoveries into therapies that hold the hope for curing cancer. Over 38 years, NFCR has been credited with many breakthroughs leading to new approaches to treating cancer.

Honoring Szent-Gyorgyi

Today, NFCR continues to honor Dr. Szent-Gyorgyi's vision through a research commitment to basic science research discoveries, flexible research grants to encourage scientists to explore unanticipated discoveries and through the annual Albert Szent-Gyorgyi Prize for Progress in Cancer Research, one of the most notable annual prizes in cancer research today. For more information, visit www.ASGPrize.org

About NFCR

Over the past 38 years, NFCR has provided more than $288 million in direct support of cutting-edge cancer research focused on understanding how and why cells become cancerous and on cancer prevention education for the public. NFCR is dedicated to funding scientists who are unraveling cancer's molecular mysteries and translating their discoveries into therapies that hold the hope for curing cancer. Visit http://www.NFCR.org or call (800) 321-CURE (2873) for more information.

Media Contact:

Silas Deane


Deane, Smith & Partners, Inc.


silas@deanesmithpartners.com


615-319-6007





SOURCE National Foundation for Cancer Research



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES